Sphera Funds Management Ltd. Coherus Bio Sciences, Inc. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $633,528 - $1.17 Million	75,600 New	75,600 $1.03 Million
Q2 2018 Aug 13, 2018	SELL	$10.25 - $17.45 $2.77 Million - $4.71 Million	-270,000 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$9.1 - $13.7 $2.46 Million - $3.7 Million	270,000 New	270,000 $2.98 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.